A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

NCT05365724 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Omicron COVID-19 Vaccine (Vero Cell), Inactivated

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]